Literature DB >> 11399519

Interferon (IFN)-gamma and Herpes simplex virus/tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1.

S R Paludan1, L Malmgaard, S Ellermann-Eriksen, L Boscá, S C Mogensen.   

Abstract

The radical nitric oxide (NO) constitutes an important part of the innate immune response to many viruses, and among these notably Herpes simplex virus (HSV). We have previously shown that HSV/tumor necrosis factor-alpha (TNF-alpha) and IFN-gamma synergistically induce NO production in macrophages, and here we have investigated the molecular mechanism underlying this phenomenon. The enhancement of NO production was regulated at the level of NO synthase 2 (NOS2, iNOS) transcription. The ISRE element of the NOS2 promoter, which binds IFN regulatory factor (IRF)-1, was essential both for full responsiveness to IFN-gamma and the synergistic response. The GAS motif, binding signal transducer and activator of transcription 1 (STAT1), did not contribute to the cross-talk with virus/TNF-induced signals, but was necessary for full responsiveness to IFN-gamma. The distal binding site for nuclear factor (NF)-kappa B was important for the cooperative response, while the proximal kappa B site was not involved in the cooperative promoter activation but played a role in full promoter inducibility. By ectopic expression of IRF-1 and NF-kappa B (p65), we found that these factors synergistically induce NO accumulation. Together, our results show that binding of IRF-1 and NF-kappa B to their respective sites in the distal domain of the NOS2 promoter, creates a potent trans-activating complex with the ability to induce NOS2 transcription synergistically in response to simultaneous HSV-2/TNF-alpha and IFN-gamma treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11399519

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  8 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2.

Authors:  Patric Lundberg; Paula V Welander; Carl K Edwards; Nico van Rooijen; Edouard Cantin
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

3.  Herpes Simplex Virus 1 Suppresses the Function of Lung Dendritic Cells via Caveolin-1.

Authors:  Bing Wu; Shuang Geng; Yanmin Bi; Hu Liu; Yanxin Hu; Xinqiang Li; Yizhi Zhang; Xiaoyu Zhou; Guoxing Zheng; Bin He; Bin Wang
Journal:  Clin Vaccine Immunol       Date:  2015-05-27

4.  A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice.

Authors:  Patric Lundberg; Paula Welander; Harry Openshaw; Christina Nalbandian; Carl Edwards; Lyle Moldawer; Edouard Cantin
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

5.  A combined carrier-adjuvant system of peptide nanofibers and toll-like receptor agonists potentiates robust CD8+ T cell responses.

Authors:  Jai S Rudra; Brianne N Banasik; Gregg N Milligan
Journal:  Vaccine       Date:  2017-12-14       Impact factor: 3.641

Review 6.  Macrophages and cytokines in the early defence against herpes simplex virus.

Authors:  Svend Ellermann-Eriksen
Journal:  Virol J       Date:  2005-08-03       Impact factor: 4.099

7.  The efficacy of SPA0355 in protecting β cells in isolated pancreatic islets and in a murine experimental model of type 1 diabetes.

Authors:  Ui-Jin Bae; Mi-Young Song; Hyun-Young Jang; Hyo Jin Gim; Jae-Ha Ryu; Sang-Myeong Lee; Raok Jeon; Byung-Hyun Park
Journal:  Exp Mol Med       Date:  2013-11-01       Impact factor: 8.718

8.  Inhibition of ERK1/2 by silymarin in mouse mesangial cells.

Authors:  Cha Kyung Youn; Sung Il Cho; Min Young Lee; Young Jin Jeon; Seog Ki Lee
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.